ZOCCHI, CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.744
AS - Asia 1.706
EU - Europa 1.482
SA - Sud America 163
AF - Africa 26
OC - Oceania 16
Totale 5.137
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.690
RU - Federazione Russa 532
SG - Singapore 483
CN - Cina 432
IT - Italia 334
HK - Hong Kong 276
PL - Polonia 138
KR - Corea 137
BR - Brasile 136
VN - Vietnam 133
IE - Irlanda 95
DE - Germania 84
BD - Bangladesh 81
SE - Svezia 77
FI - Finlandia 60
IN - India 52
FR - Francia 40
GB - Regno Unito 39
CA - Canada 31
JO - Giordania 30
TR - Turchia 23
NL - Olanda 19
AU - Australia 16
ID - Indonesia 16
UA - Ucraina 15
AR - Argentina 14
JP - Giappone 14
CH - Svizzera 13
ES - Italia 13
MX - Messico 12
NG - Nigeria 7
ZA - Sudafrica 5
CI - Costa d'Avorio 4
IQ - Iraq 4
PK - Pakistan 4
PT - Portogallo 4
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
BE - Belgio 3
BJ - Benin 3
CO - Colombia 3
EC - Ecuador 3
LT - Lituania 3
NI - Nicaragua 3
AT - Austria 2
GR - Grecia 2
IL - Israele 2
JM - Giamaica 2
KZ - Kazakistan 2
LU - Lussemburgo 2
OM - Oman 2
PE - Perù 2
PH - Filippine 2
TW - Taiwan 2
AG - Antigua e Barbuda 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BW - Botswana 1
BY - Bielorussia 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
GA - Gabon 1
GT - Guatemala 1
HN - Honduras 1
KE - Kenya 1
MA - Marocco 1
MU - Mauritius 1
MY - Malesia 1
NO - Norvegia 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 5.137
Salva come PNG Salva come JPEG
Città #
Santa Clara 419
Singapore 365
Ashburn 265
Hong Kong 260
Hefei 149
Seoul 137
Warsaw 132
San Jose 104
Dublin 95
Chandler 71
Milan 63
Beijing 57
Fairfield 53
Los Angeles 51
Munich 47
New York 45
Ho Chi Minh City 43
Florence 40
Buffalo 39
Hanoi 35
Rome 31
Helsinki 28
Lauterbourg 26
Houston 25
Seattle 24
Moscow 23
Altamura 22
Lawrence 22
Mumbai 21
Turku 21
Council Bluffs 20
Cambridge 18
Kent 18
Wilmington 18
Frankfurt am Main 17
Princeton 17
Woodbridge 17
Melbourne 16
Boston 14
Jakarta 14
Tokyo 14
Adapazarı 13
Bern 13
Shanghai 12
São Paulo 12
The Dalles 12
Dallas 11
Dnipro 11
Toronto 11
Da Nang 10
Lappeenranta 10
Naples 10
Bengaluru 9
Figino 9
London 9
Montreal 9
San Diego 9
Turin 9
Ann Arbor 7
Chennai 7
Medford 7
Phoenix 7
Stockholm 7
Chicago 6
Düsseldorf 6
Hillsboro 6
Istanbul 6
Orem 6
Rio de Janeiro 6
Abuja 5
Barnet 5
Boardman 5
Guangzhou 5
Haiphong 5
Mexico City 5
Abidjan 4
Atlanta 4
Barcelona 4
Brasília 4
Brooklyn 4
Denver 4
Manchester 4
North Bergen 4
Padua 4
Paris 4
Poplar 4
San Francisco 4
Shenzhen 4
West Jordan 4
Wroclaw 4
Yubileyny 4
Amsterdam 3
Bari 3
Buenos Aires 3
Bắc Ninh 3
Campinas 3
Clifton 3
Cotonou 3
Dhaka 3
Johannesburg 3
Totale 3.267
Salva come PNG Salva come JPEG
Nome #
Clinical events beyond one year after an acute coronary syndrome: Insights from the RECLOSE 2-ACS study 349
Optimal timing of follow-up cardiac magnetic resonance in patients with uncomplicated acute myocarditis 275
Clinical staging of Anderson-Fabry cardiomyopathy: An operative proposal 209
Changes in the perceived epidemiology of amyloidosis: 20 year-experience from a Tertiary Referral Centre in Tuscany 198
Risk stratification using the CHA2DS2-VASc score in Takotsubo syndrome: Data from the Takotsubo Italian network 185
Myocardial infarction with non-obstructive coronary arteries in hypertrophic cardiomyopathy vs Fabry disease 173
Incidence of stroke in patients with hypertrophic cardiomyopathy in stable sinus rhythm during long-term monitoring 172
Emerging Medical Treatment for Hypertrophic Cardiomyopathy 170
Early Diagnosis and Outcome in Patients With Wild-Type Transthyretin Cardiac Amyloidosis 168
Factors associated with persistence of symptoms 1 year after COVID-19: A longitudinal, prospective phone-based interview follow-up cohort study 163
Relationship between hyponatremia at hospital admission and cardiopulmonary profile at follow-up in patients with SARS-CoV-2 (COVID-19) infection 161
Assessing cardiac mechanics through left ventricular haemodynamic forces 159
Clinical scenarios of HCM-related mortality: Relevance of age and stage of disease at presentation 159
Impact of Pregnancy on the Natural History of Women with Hypertrophic Cardiomyopathy 155
Strength of clinical indication and therapeutic impact of the implantable cardioverter defibrillator in patients with hypertrophic cardiomyopathy 154
Cellular determinants of arrhythmic rysk in hypertrophic cardiomyopathy 153
Discriminatory ability of CHA2DS2-VASc score to predict residual platelet reactivity and outcomes in patients with acute coronary syndrome 150
Decrease and Delay in Hospitalization for Acute Coronary Syndromes During the 2020 SARS-CoV-2 Pandemic 143
Incidence of light chain amyloidosis in Florence metropolitan area, Italy: a population-based study 143
Prevalence and predictors of bradyarrhythmias requiring permanent pacing in patients with Anderson-Fabry disease 141
Prevalence and prognostic role of nonsustained ventricular tachycardia in cardiac amyloidosis 139
Prevalence of Inherited Cardiac Diseases Among Young Patients Requiring Permanent Pacing 139
Sex-related differences in clinical presentation and all-cause mortality in patients with cardiac transthyretin amyloidosis and light chain amyloidosis 132
Clinical course and outcome of pregnancy in patients with hypertrophic cardiomyopathy 132
Atlas of Regional Left Ventricular Scar in Nonischemic Cardiomyopathies: Substrates and Etiologies 127
Predicting Mortality Risk in Older Hospitalized Persons With COVID-19: A Comparison of the COVID-19 Mortality Risk Score with Frailty and Disability 126
Myocarditis and COVID-19 related issues 122
Relation between post-myocardial infarct remodelling and gelatinase activity in patients enrolled in the TIPTOP trial 117
Radiomics of Late Gadolinium Enhancement Reveals Prognostic Value of Myocardial Scar Heterogeneity in Hypertrophic Cardiomyopathy 111
Role of advanced CMR features in identifying a positive genotype of hypertrophic cardiomyopathy 107
SUDDEN DEATH RISK AMONG HYPERTROPHIC CARDIOMYOPATHY PATIENTS WITH LEFT VENTRICULAR APICAL ANEURYSMS: DOES SIZE MATTER? 94
Correction to: Clinical staging of Anderson‑Fabry cardiomyopathy: an operative proposal 94
Factors associated with persistent symptoms after COVID-19 infection: a longitudinal study on an Italian cohort of patients discharged from hospital 43
Factors associated with persistent symptoms after COVID-19 infection: a longitudinal study on an Italian cohort of patients discharged from hospital 42
Screening for dilated cardiomyopathy in immediate family members: to whom, how, when (and where) 33
Changes in CMR-derived ventricular strain, fibrosis progression and outcomes in hypertrophic cardiomyopathy 29
Cardiac involvement in Fabry disease: Recent advances, unresolved issues, and unmet needs 21
Totale 5.188
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.433
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.433
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022134 10 1 7 0 2 7 0 12 19 9 27 40
2022/2023405 29 74 20 14 21 67 56 30 52 7 15 20
2023/2024234 5 22 24 11 17 31 14 55 6 19 21 9
2024/20251.673 36 139 74 241 342 212 47 81 193 55 95 158
2025/20262.396 225 311 278 268 235 79 235 93 171 145 114 242
2026/202764 64 0 0 0 0 0 0 0 0 0 0 0
Totale 5.188